Dec 15 (Reuters) - The U.S. Food and Drug Administration has approved Daiichi Sankyo's therapy in combination with Roche's ...

A mom was overjoyed when she learned a gene therapy treatment could save her child's life, until she found out no one would cover the $2 million price tag.

Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the ...

The Cuyahoga County Prosecutor Michael C. O’Malley announced that the Cuyahoga County grand jury returned an indictment of 37 ...

Dec 15 (Reuters) - UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma ...

Medetomidine, a veterinary sedative mixed into fentanyl, has sent thousands to hospitals, not only for overdose but for life-threatening withdrawal. It is spreading to other cities.

By Christy Santhosh and Sriparna Roy Dec 11 (Reuters) - Eli Lilly said on Thursday its next-generation obesity drug helped ...

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

By Siddhi Mahatole Dec 15 (Reuters) - Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 25% in morning ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to ...

When insurance twice refused to cover a nearly $800,000-a-year drug that Paxton Pope’s doctor believed could dramatically ...

The Medicare prescription drug plan market appears to be under a lot of stress. And taxpayers are forking over record amounts ...